Recombinant Human Interferon alpha 2b (rIFN alpha 2b, rDNA Origin) Cream(1 x10⁵ IU/tube)---5g/tube
[PRODUCT NAME]
Generic name: Recombinant Human Interferon alpha 2b Cream
Trade name: Anterferon®
Chinese phoneticize: Zhusheyong Chongzu Ren Ganraosu alpha 2b Rugao
Composition: Recombinant Human Interferon alpha 2b
[DESCRIPTION]
White cream
[PHARMACOLOGICAL ACTIONS]
Interferon alpha 2b exerts actions of antiviral and regulating immunity. Such immunomodulation activities include enhancement of the phagocytes for target cells, and enhancement of the NK cell activities.
[INDICATIONS]
Verruca acuminata induced by human papilloma, Herpes labiali induced by simplify herpes virus and phaltic herpes.
[ADMINISTRATION AND DOSAGE]
Daub affected part, four times daily.
Administer drugs 6-8 weeks for verruca acuminata, or under medical supervision. Administer drugs one week for herpes labiali and phaltic herpes or under supervision.
[ADVERSE REACTIONS]
No stimulation, irritability and other whole body adverse reactions have been reported. Light pruritus and causalgia could occur in individual patient.
[CONTRAINDICATIONS]
It is contraindicated in those patients who have hypersensitivity to this drugs
[PRECAUTIONS]
It is contraindicated in those patients who have hypersensitivity to this drug
[PRECAUTIONS]
1. Cautious dosage is advised in patients who hypersensitivity to interferon.
2. Keep out of reach of eyes.
[PREGNANCY AND BABY-NURSING WOMEN]
Use under advice of doctors.
[PEDIATRICS]
Experience in pediareics is limited.
[OLD PATIENTS]
Experience in old patient is limited
[INTERACTION WITH OTHER DRUGS]
1. There are no reports about interactions with other medicines..
2. Use separately from other external drugs to get better therapy.
[OVERDOSAGE]
No serious adverse reactions for over-dosage have been reported. Attention should be given to dosage during therapy.
[VIAL SIZE]
1 million IU/tube (5g/tube)
[STORAGE]
Dark at 0-20ºC and keep dry.
[EXPIRY]
18 months
[LICENSE NUMBER]
S20010054
[MANUFACTURED BY]
Zhaoke Biotechnology (hefei) Co., Ltd.
